139 related articles for article (PubMed ID: 25377955)
1. Neoadjuvant treatment combined with planned surgery in laryngeal function preservation for locally advanced pyriform sinus carcinoma.
Yu Y; Wang X; Xu Z; Fan C; Tu G
J Craniofac Surg; 2014 Nov; 25(6):1975-9. PubMed ID: 25377955
[TBL] [Abstract][Full Text] [Related]
2. [Surgical management of elderly patients with medial wall pyriform sinus cancer].
Wang Q; Liu YH; Hu GQ; Wu KL; Tong BS; Gao CB; Zhao Y
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):931-936. PubMed ID: 29262511
[No Abstract] [Full Text] [Related]
3. [Long-term outcome of patients with pyriform sinus squamous cell carcinoma treated with planned preoperative (chemo-) radiotherapy plus laryngeal function sparing surgery].
Huang H; Zhang ZM; Zhang Y; Wang XL; Liu SY; Xu ZG
Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):535-539. PubMed ID: 31357842
[No Abstract] [Full Text] [Related]
4. [Surgical treatment on primary lesion of advanced pyriform sinus cancer].
Wang XL; Xu ZG; Tang PZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):534-7. PubMed ID: 16995308
[TBL] [Abstract][Full Text] [Related]
5. Oncological and functional outcomes of trans-oral robotic surgery for pyriform sinus carcinoma: A French GETTEC group study.
Mazerolle P; Philouze P; Garrel R; Aubry K; Morinière S; El Bedoui S; Ton Van J; Ferron C; Malard O; Jegoux F; Berard E; Vergez S
Oral Oncol; 2018 Nov; 86():165-170. PubMed ID: 30409296
[TBL] [Abstract][Full Text] [Related]
6. Laryngeal preservation in advanced piriform sinus squamous cell carcinomas using superselective intra-arterial chemoradiation therapy with three agents.
Furusaka T; Matsuda A; Tanaka A; Matsuda H; Ikeda M
Acta Otolaryngol; 2013 Mar; 133(3):318-26. PubMed ID: 23153059
[TBL] [Abstract][Full Text] [Related]
7. Pyriform sinus squamous cell carcinoma: oncological outcomes in good responders of induction chemotherapy-based larynx preservation protocols.
Vourexakis Z; Le Ridant AM; Dulguerov P; Janot F
Eur Arch Otorhinolaryngol; 2015 Jul; 272(7):1725-31. PubMed ID: 24854231
[TBL] [Abstract][Full Text] [Related]
8. [Comprehensive treatment of 335 patients with pyriform sinus carcinoma by surgery via the paraglottic space approach].
Li WM; Wei DM; Qian Y; Cao SD; Xu Y; Liu DY; Lei DP; Pan XL
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):339-345. PubMed ID: 29764014
[No Abstract] [Full Text] [Related]
9. [Analysis of the therapeutic efficacy for 60 cases of T4 squamous cell carcinoma of the pyriform sinus].
Huang H; Xu ZG; Luo JW
Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):152-5. PubMed ID: 21575488
[TBL] [Abstract][Full Text] [Related]
10. A pyriform sinus cancer organ preservation strategy comprising induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, followed by potentiated radiotherapy: a multicenter, retrospective study.
Céruse P; Cosmidis A; Belot A; Rabilloud M; Fuchsmann C; Poupart M; Ramade A; Tartas S; Favrel V; Pommier P; Zrounba P; Fayette J
Anticancer Drugs; 2014 Sep; 25(8):970-5. PubMed ID: 24849707
[TBL] [Abstract][Full Text] [Related]
11. Preservation of laryngeal functions in surgical treatment of pyriform sinus carcinoma.
Li XZ; Jin T; Cai XL; Pan XL
Acta Otolaryngol; 2011 Mar; 131(3):316-22. PubMed ID: 21133828
[TBL] [Abstract][Full Text] [Related]
12. [Treatment and prognosis of 264 patients with hypopharyngeal carcinoma].
Xu W; Lyu ZH; Sa N; Ma JK; Tian JJ; Feng SH; Cui P; Cao HY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):346-351. PubMed ID: 29764015
[No Abstract] [Full Text] [Related]
13. Randomized phase III trial comparing induction chemotherapy followed by radiotherapy to concomitant chemoradiotherapy for laryngeal preservation in T3M0 pyriform sinus carcinoma.
Prades JM; Lallemant B; Garrel R; Reyt E; Righini C; Schmitt T; Remini N; Saban-Roche L; Timoshenko AP; Trombert B; Guerrier B
Acta Otolaryngol; 2010; 130(1):150-5. PubMed ID: 19449227
[TBL] [Abstract][Full Text] [Related]
14. Surgical approach of laryngofissure combined with epiglottis valley in treating locally-advanced pyriform sinus carcinoma.
Wu P; Tang Y; Fang X; Zhao S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 46(8):843-850. PubMed ID: 34565728
[TBL] [Abstract][Full Text] [Related]
15. 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx.
Roh JL; Pae KH; Choi SH; Kim JS; Lee S; Kim SB; Nam SY; Kim SY
Eur J Surg Oncol; 2007 Aug; 33(6):790-5. PubMed ID: 17306956
[TBL] [Abstract][Full Text] [Related]
16. Organ preservation surgery for pyriform sinus carcinoma with vocal cord fixation: functional and oncological outcomes.
Xu S; Huang Y; Huang H; Qian J; Wang K; Wu Y; Wang X; Xu Z; Liu S; Liu J
Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3611-3617. PubMed ID: 34825265
[TBL] [Abstract][Full Text] [Related]
17. [Laryngeal function preservated surgery for piriform sinus carcinoma with paraglottic space involvement].
Li W; Yi X; Yang L; Qin W; Chen M
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 May; 28(9):601-3. PubMed ID: 25195263
[TBL] [Abstract][Full Text] [Related]
18. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer.
Zelefsky MJ; Kraus DH; Pfister DG; Raben A; Shah JP; Strong EW; Spiro RH; Bosl GJ; Harrison LB
Head Neck; 1996; 18(5):405-11. PubMed ID: 8864731
[TBL] [Abstract][Full Text] [Related]
19. [Surgical management of aged patients with hypopharyngeal carcinoma and preservation of laryngeal function].
Zhang DG; Luan XY; Pan XL; Xie G
Ai Zheng; 2005 Nov; 24(11):1372-5. PubMed ID: 16552966
[TBL] [Abstract][Full Text] [Related]
20. [Result analysis of perioperative radiotherapy and laryngeal preservation in hypopharyngeal and pyriform sinus squamous cell carcinoma].
Wang JH; Qi YF; Tang PZ; Xu ZG; Wen SX; Liu MB
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Jul; 40(7):528-32. PubMed ID: 16200964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
